< 0 1 0 1 O
17 1 3 1 3 B-upper_bound
years 4 9 4 9 I-upper_bound
of 10 12 10 12 O
age 13 16 13 16 B-age
at 17 19 17 19 O
the 20 23 20 23 O
time 24 28 24 28 O
of 29 31 29 31 O
dosing 32 38 32 38 O

Consumes 0 8 39 47 O
alcohol- 9 17 48 56 O
, 17 18 56 57 O
caffeine- 19 28 58 67 O
, 28 29 67 68 O
or 30 32 69 71 O
xanthine 33 41 72 80 O
- 41 42 80 81 O
containing 42 52 81 91 O
products 53 61 92 100 O
within 62 68 101 107 O
48 69 71 108 110 B-upper_bound
hours 72 77 111 116 I-upper_bound
before 78 84 117 123 O
dosing 85 91 124 130 O
and 92 95 131 134 O
during 96 102 135 141 O
periods 103 110 142 149 O
when 111 115 150 154 O
blood 116 121 155 160 O
samples 122 129 161 168 O
are 130 133 169 172 O
collected 134 143 173 182 O

Consumes 0 8 183 191 O
grapefruit 9 19 192 202 O
, 19 20 202 203 O
grapefruit 21 31 204 214 O
products 32 40 215 223 O
, 40 41 223 224 O
Seville 42 49 225 232 O
oranges 50 57 233 240 O
, 57 58 240 241 O
or 59 61 242 244 O
pomelo 62 68 245 251 O
- 68 69 251 252 O
containing 69 79 252 262 O
products 80 88 263 271 O
within 89 95 272 278 O
14 96 98 279 281 B-upper_bound
days 99 103 282 286 I-upper_bound
of 104 106 287 289 O
dosing 107 113 290 296 O

Donated 0 7 297 304 O
blood 8 13 305 310 O
within 14 20 311 317 O
28 21 23 318 320 B-upper_bound
days 24 28 321 325 I-upper_bound
or 29 31 326 328 O
plasma 32 38 329 335 B-clinical_variable
within 39 45 336 342 O
14 46 48 343 345 B-upper_bound
days 49 53 346 350 I-upper_bound
of 54 56 351 353 O
dosing 57 63 354 360 O
or 64 66 361 363 O
plans 67 72 364 369 O
to 73 75 370 372 O
donate 76 82 373 379 O
them 83 87 380 384 O
within 88 94 385 391 O
4 95 96 392 393 B-upper_bound
weeks 97 102 394 399 I-upper_bound
after 103 108 400 405 I-upper_bound
completing 109 119 406 416 O
the 120 123 417 420 O
study 124 129 421 426 O

Had 0 3 427 430 O
a 4 5 431 432 O
clinically 6 16 433 443 O
significant 17 28 444 455 O
illness 29 36 456 463 O
, 36 37 463 464 O
except 38 44 465 471 O
for 45 48 472 475 O
the 49 52 476 479 O
condition 53 62 480 489 O
for 63 66 490 493 O
which 67 72 494 499 O
the 73 76 500 503 O
procedure 77 86 504 513 O
is 87 89 514 516 O
being 90 95 517 522 O
performed 96 105 523 532 O
, 105 106 532 533 O
in 107 109 534 536 O
the 110 113 537 540 O
28 114 116 541 543 B-upper_bound
days 117 121 544 548 I-upper_bound
before 122 128 549 555 I-upper_bound
dosing 129 135 556 562 O
with 136 140 563 567 O
study 141 146 568 573 B-treatment
drug 147 151 574 578 I-treatment
as 152 154 579 581 O
determined 155 165 582 592 O
by 166 168 593 595 O
the 169 172 596 599 O
clinical 173 181 600 608 O
investigator 182 194 609 621 O

Has 0 3 622 625 O
a 4 5 626 627 O
history 6 13 628 635 O
of 14 16 636 638 O
relevant 17 25 639 647 O
drug 26 30 648 652 B-allergy_name
allergies 31 40 653 662 O
, 40 41 662 663 O
food 42 46 664 668 B-allergy_name
allergies 47 56 669 678 O
, 56 57 678 679 O
or 58 60 680 682 O
both 61 65 683 687 O
( 66 67 688 689 O
i.e. 67 71 689 693 O
, 71 72 693 694 O
allergy 73 80 695 702 O
to 81 83 703 705 O
oxycodone 84 93 706 715 B-allergy_name
, 93 94 715 716 O
allergy 95 102 717 724 O
to 103 105 725 727 O
related 106 113 728 735 O
drugs 114 119 736 741 B-allergy_name
, 119 120 741 742 O
or 121 123 743 745 O
any 124 127 746 749 O
significant 128 139 750 761 O
food 140 144 762 766 O
allergy 145 152 767 774 O
that 153 157 775 779 O
could 158 163 780 785 O
interfere 164 173 786 795 O
with 174 178 796 800 O
the 179 182 801 804 O
study 183 188 805 810 O
) 188 189 810 811 O

Has 0 3 812 815 O
a 4 5 816 817 O
negative 6 14 818 826 B-pregnancy
serum 15 20 827 832 I-pregnancy
pregnancy 21 30 833 842 I-pregnancy
test 31 35 843 847 O
at 36 38 848 850 O
Screening 39 48 851 860 O
and 49 52 861 864 O
predose 53 60 865 872 O
check 61 66 873 878 O
in 67 69 879 881 O
for 70 73 882 885 O
females 74 81 886 893 B-gender
of 82 84 894 896 O
childbearing 85 97 897 909 O
potential 98 107 910 919 O

Has 0 3 920 923 O
a 4 5 924 925 O
positive 6 14 926 934 O
test 15 19 935 939 O
result 20 26 940 946 O
for 27 30 947 950 O
hepatitis 31 40 951 960 B-chronic_disease
B 41 42 961 962 I-chronic_disease
surface 43 50 963 970 O
antigen 51 58 971 978 O
, 58 59 978 979 O
hepatitis 60 69 980 989 B-chronic_disease
C 70 71 990 991 I-chronic_disease
antibody 72 80 992 1000 O
, 80 81 1000 1001 O
or 82 84 1002 1004 O
human 85 90 1005 1010 B-chronic_disease
immunodeficiency 91 107 1011 1027 I-chronic_disease
virus 108 113 1028 1033 I-chronic_disease
antibody 114 122 1034 1042 O

Has 0 3 1043 1046 O
an 4 6 1047 1049 O
indwelling 7 17 1050 1060 O
access 18 24 1061 1067 O
catheter 25 33 1068 1076 B-treatment
for 34 37 1077 1080 O
blood 38 43 1081 1086 O
sampling 44 52 1087 1095 O

Has 0 3 1096 1099 O
taken 4 9 1100 1105 O
oxycodone 10 19 1106 1115 B-treatment
or 20 22 1116 1118 O
oxymorphone 23 34 1119 1130 B-treatment
within 35 41 1131 1137 O
the 42 45 1138 1141 O
48 46 48 1142 1144 B-upper_bound
hours 49 54 1145 1150 I-upper_bound
before 55 61 1151 1157 O
anticipated 62 73 1158 1169 O
dosing 74 80 1170 1176 O
with 81 85 1177 1181 O
study 86 91 1182 1187 B-treatment
drug 92 96 1188 1192 I-treatment

Has 0 3 1193 1196 O
the 4 7 1197 1200 O
presence 8 16 1201 1209 O
or 17 19 1210 1212 O
history 20 27 1213 1220 O
of 28 30 1221 1223 O
a 31 32 1224 1225 O
clinically 33 43 1226 1236 O
significant 44 55 1237 1248 O
disorder 56 64 1249 1257 O
involving 65 74 1258 1267 O
the 75 78 1268 1271 O
cardiovascular 79 93 1272 1286 B-chronic_disease
, 93 94 1286 1287 O
respiratory 95 106 1288 1299 B-chronic_disease
, 106 107 1299 1300 O
renal 108 113 1301 1306 B-chronic_disease
, 113 114 1306 1307 O
gastrointestinal 115 131 1308 1324 B-chronic_disease
, 131 132 1324 1325 O
immunologic 133 144 1326 1337 B-chronic_disease
, 144 145 1337 1338 O
hematologic 146 157 1339 1350 B-chronic_disease
, 157 158 1350 1351 O
endocrine 159 168 1352 1361 B-chronic_disease
, 168 169 1361 1362 O
or 170 172 1363 1365 O
neurologic 173 183 1366 1376 B-chronic_disease
system(s 184 192 1377 1385 I-chronic_disease
) 192 193 1385 1386 I-chronic_disease
or 194 196 1387 1389 O
psychiatric 197 208 1390 1401 B-chronic_disease
disease 209 216 1402 1409 I-chronic_disease
( 217 218 1410 1411 O
except 218 224 1411 1417 O
for 225 228 1418 1421 O
the 229 232 1422 1425 O
condition 233 242 1426 1435 O
for 243 246 1436 1439 O
which 247 252 1440 1445 O
the 253 256 1446 1449 O
procedure 257 266 1450 1459 O
is 267 269 1460 1462 O
being 270 275 1463 1468 O
performed 276 285 1469 1478 O
) 285 286 1478 1479 O
as 287 289 1480 1482 O
determined 290 300 1483 1493 O
by 301 303 1494 1496 O
the 304 307 1497 1500 O
clinical 308 316 1501 1509 O
investigator 317 329 1510 1522 O

Received 0 8 1523 1531 O
an 9 11 1532 1534 O
investigational 12 27 1535 1550 B-treatment
drug 28 32 1551 1555 I-treatment
within 33 39 1556 1562 O
28 40 42 1563 1565 B-upper_bound
days 43 47 1566 1570 I-upper_bound
of 48 50 1571 1573 O
dosing 51 57 1574 1580 O

Subject 0 7 1581 1588 O
2 8 9 1589 1590 O
to 10 12 1591 1593 O
< 13 14 1594 1595 O
17 14 16 1595 1597 B-upper_bound
years 17 22 1598 1603 I-upper_bound
of 23 25 1604 1606 O
age 26 29 1607 1610 B-age
, 29 30 1610 1611 O
be 31 33 1612 1614 O
in 34 36 1615 1617 O
at 37 39 1618 1620 O
least 40 45 1621 1626 O
the 46 49 1627 1630 O
25 50 52 1631 1633 B-lower_bound
% 52 53 1633 1634 I-lower_bound
for 54 57 1635 1638 O
weight 58 64 1639 1645 O
according 65 74 1646 1655 O
to 75 77 1656 1658 O
the 78 81 1659 1662 O
Center 82 88 1663 1669 O
for 89 92 1670 1673 O
Disease 93 100 1674 1681 O
Control 101 108 1682 1689 O
pediatric 109 118 1690 1699 O
growth 119 125 1700 1706 O
charts 126 132 1707 1713 O
and 133 136 1714 1717 O
weighs 137 143 1718 1724 O
at 144 146 1725 1727 O
least 147 152 1728 1733 O
28 153 155 1734 1736 B-lower_bound
lb 156 158 1737 1739 I-lower_bound
at 159 161 1740 1742 O
the 162 165 1743 1746 O
time 166 170 1747 1751 O
of 171 173 1752 1754 O
dosing 174 180 1755 1761 O
with 181 185 1762 1766 O
study 186 191 1767 1772 O
drug 192 196 1773 1777 O

Subject 0 7 1778 1785 O
2 8 9 1786 1787 B-lower_bound
to 10 12 1788 1790 O
< 13 14 1791 1792 O
17 14 16 1792 1794 B-upper_bound
years 17 22 1795 1800 I-upper_bound
of 23 25 1801 1803 O
age 26 29 1804 1807 B-age
, 29 30 1807 1808 O
has 31 34 1809 1812 O
a 35 36 1813 1814 O
positive 37 45 1815 1823 O
urine 46 51 1824 1829 O
test 52 56 1830 1834 O
result 57 63 1835 1841 O
for 64 67 1842 1845 O
drugs 68 73 1846 1851 O
of 74 76 1852 1854 O
abuse 77 82 1855 1860 O
( 83 84 1861 1862 O
amphetamines 84 96 1862 1874 O
, 96 97 1874 1875 O
barbiturates 98 110 1876 1888 O
, 110 111 1888 1889 O
cannabinoids 112 124 1890 1902 O
, 124 125 1902 1903 O
cocaine 126 133 1904 1911 O
metabolites 134 145 1912 1923 O
, 145 146 1923 1924 O
opiates 147 154 1925 1932 O
, 154 155 1932 1933 O
phencyclidine 156 169 1934 1947 O
, 169 170 1947 1948 O
and 171 174 1949 1952 O
benzodiazepines 175 190 1953 1968 O
) 190 191 1968 1969 O
or 192 194 1970 1972 O
alcohol 195 202 1973 1980 O
at 203 205 1981 1983 O
Screening 206 215 1984 1993 O
( 216 217 1994 1995 O
not 217 220 1995 1998 O
required 221 229 1999 2007 O
for 230 233 2008 2011 O
subjects 234 242 2012 2020 O
less 243 247 2021 2025 O
than 248 252 2026 2030 O
2 253 254 2031 2032 B-upper_bound
years 255 260 2033 2038 I-upper_bound
of 261 263 2039 2041 O
age 264 267 2042 2045 O
) 267 268 2045 2046 O

Use 0 3 2047 2050 O
of 4 6 2051 2053 O
St. 7 10 2054 2057 B-treatment
John 11 15 2058 2062 I-treatment
's 15 17 2062 2064 I-treatment
wort 18 22 2065 2069 I-treatment
is 23 25 2070 2072 O
prohibited 26 36 2073 2083 O
from 37 41 2084 2088 O
28 42 44 2089 2091 B-upper_bound
days 45 49 2092 2096 I-upper_bound
before 50 56 2097 2103 O
dosing 57 63 2104 2110 O
until 64 69 2111 2116 O
14 70 72 2117 2119 B-upper_bound
days 73 77 2120 2124 I-upper_bound
after 78 83 2125 2130 O
dosing 84 90 2131 2137 O

Use 0 3 2138 2141 O
of 4 6 2142 2144 O
all 7 10 2145 2148 O
other 11 16 2149 2154 O
prescription 17 29 2155 2167 B-treatment
medications 30 41 2168 2179 I-treatment
, 41 42 2179 2180 O
except 43 49 2181 2187 O
required 50 58 2188 2196 O
pre 59 62 2197 2200 B-treatment
- 62 63 2200 2201 I-treatment
op 63 65 2201 2203 I-treatment
medications 66 77 2204 2215 I-treatment
and 78 81 2216 2219 O
birth 82 87 2220 2225 O
control 88 95 2226 2233 O
, 95 96 2233 2234 O
is 97 99 2235 2237 O
prohibited 100 110 2238 2248 O
within 111 117 2249 2255 O
3 118 119 2256 2257 B-upper_bound
days 120 124 2258 2262 I-upper_bound
of 125 127 2263 2265 O
dosing 128 134 2266 2272 O
with 135 139 2273 2277 O
study 140 145 2278 2283 B-treatment
drug 146 150 2284 2288 I-treatment

Use 0 3 2289 2292 O
of 4 6 2293 2295 O
any 7 10 2296 2299 O
over 11 15 2300 2304 B-treatment
- 15 16 2304 2305 I-treatment
the 16 19 2305 2308 I-treatment
- 19 20 2308 2309 I-treatment
counter 20 27 2309 2316 I-treatment
medications 28 39 2317 2328 I-treatment
( 40 41 2329 2330 O
including 41 50 2330 2339 O
herbal 51 57 2340 2346 B-treatment
or 58 60 2347 2349 I-treatment
dietary 61 68 2350 2357 I-treatment
supplements 69 80 2358 2369 I-treatment
and 81 84 2370 2373 O
therapeutic 85 96 2374 2385 B-treatment
doses 97 102 2386 2391 I-treatment
of 103 105 2392 2394 I-treatment
vitamins 106 114 2395 2403 I-treatment
) 114 115 2403 2404 O
, 115 116 2404 2405 O
except 117 123 2406 2412 O
for 124 127 2413 2416 O
required 128 136 2417 2425 O
pre 137 140 2426 2429 B-treatment
- 140 141 2429 2430 I-treatment
op 141 143 2430 2432 I-treatment
medications 144 155 2433 2444 I-treatment
, 155 156 2444 2445 O
is 157 159 2446 2448 O
prohibited 160 170 2449 2459 O
within 171 177 2460 2466 O
24 178 180 2467 2469 B-upper_bound
hours 181 186 2470 2475 I-upper_bound
of 187 189 2476 2478 O
dosing 190 196 2479 2485 O
with 197 201 2486 2490 O
study 202 207 2491 2496 O
drug 208 212 2497 2501 O
, 212 213 2501 2502 O
with 214 218 2503 2507 O
the 219 222 2508 2511 O
exception 223 232 2512 2521 O
of 233 235 2522 2524 O
topical 236 243 2525 2532 O
spermicide 244 254 2533 2543 O

Uses 0 4 2544 2548 O
any 5 8 2549 2552 O
medication 9 19 2553 2563 B-treatment
known 20 25 2564 2569 O
to 26 28 2570 2572 O
be 29 31 2573 2575 O
an 32 34 2576 2578 O
inhibitor 35 44 2579 2588 O
or 45 47 2589 2591 O
inducer 48 55 2592 2599 O
of 56 58 2600 2602 O
CYP3A4 59 65 2603 2609 B-treatment
within 66 72 2610 2616 O
14 73 75 2617 2619 B-upper_bound
days 76 80 2620 2624 I-upper_bound
( 81 82 2625 2626 O
for 82 85 2626 2629 O
inhibitors 86 96 2630 2640 O
such 97 101 2641 2645 O
as 102 104 2646 2648 O
the 105 108 2649 2652 O
azole 109 114 2653 2658 B-treatment
- 114 115 2658 2659 I-treatment
antifungal 115 125 2659 2669 I-treatment
agents 126 132 2670 2676 I-treatment
voriconazole 133 145 2677 2689 B-treatment
and 146 149 2690 2693 O
ketoconazole 150 162 2694 2706 B-treatment
, 162 163 2706 2707 O
macrolide 164 173 2708 2717 B-treatment
antibiotics 174 185 2718 2729 I-treatment
such 186 190 2730 2734 O
as 191 193 2735 2737 O
erythromycin 194 206 2738 2750 B-treatment
, 206 207 2750 2751 O
and 208 211 2752 2755 O
protease 212 220 2756 2764 B-treatment
inhibitors 221 231 2765 2775 I-treatment
such 232 236 2776 2780 O
as 237 239 2781 2783 O
ritonavir 240 249 2784 2793 B-treatment
) 249 250 2793 2794 O
or 251 253 2795 2797 O
28 254 256 2798 2800 O
days 257 261 2801 2805 O
( 262 263 2806 2807 O
for 263 266 2807 2810 O
inducers 267 275 2811 2819 O
such 276 280 2820 2824 O
as 281 283 2825 2827 O
rifampin 284 292 2828 2836 B-treatment
, 292 293 2836 2837 O
carbamazepine 294 307 2838 2851 B-treatment
, 307 308 2851 2852 O
and 309 312 2853 2856 O
phenytoin 313 322 2857 2866 B-treatment
) 322 323 2866 2867 O
of 324 326 2868 2870 O
dosing 327 333 2871 2877 O
with 334 338 2878 2882 O
study 339 344 2883 2888 O
drug 345 349 2889 2893 O

a 0 1 2894 2895 O
smoker 2 8 2896 2902 O
or 9 11 2903 2905 O
has 12 15 2906 2909 O
used 16 20 2910 2914 O
nicotine 21 29 2915 2923 O
or 30 32 2924 2926 O
nicotine 33 41 2927 2935 O
- 41 42 2935 2936 O
containing 42 52 2936 2946 O
products 53 61 2947 2955 O
within 62 68 2956 2962 O
30 69 71 2963 2965 B-upper_bound
days 72 76 2966 2970 I-upper_bound
of 77 79 2971 2973 O
dosing 80 86 2974 2980 O

an 0 2 2981 2983 O
outpatient 3 13 2984 2994 O
for 14 17 2995 2998 O
a 18 19 2999 3000 O
surgical 20 28 3001 3009 B-treatment
procedure 29 38 3010 3019 I-treatment
and 39 42 3020 3023 O
is 43 45 3024 3026 O
expected 46 54 3027 3035 O
to 55 57 3036 3038 O
remain 58 64 3039 3045 O
hospitalized 65 77 3046 3058 O
for 78 81 3059 3062 O
at 82 84 3063 3065 O
least 85 90 3066 3071 O
24 91 93 3072 3074 B-lower_bound
hours 94 99 3075 3080 I-lower_bound
after 100 105 3081 3086 I-lower_bound
dosing 106 112 3087 3093 O
with 113 117 3094 3098 O
study 118 123 3099 3104 O
drug 124 128 3105 3109 O

female 0 6 3110 3116 B-gender

intolerant 0 10 3117 3127 O
to 11 13 3128 3130 O
direct 14 20 3131 3137 O
venipuncture 21 33 3138 3150 B-treatment

lactating 0 9 3151 3160 O
or 10 12 3161 3163 O
breastfeeding 13 26 3164 3177 O
female 27 33 3178 3184 B-gender

male 0 4 3185 3189 B-gender

